Brooker Simon, Kabatereine Narcis B, Myatt Mark, Russell Stothard J, Fenwick Alan
London School of Hygiene and Tropical Medicine, London, UK.
Trop Med Int Health. 2005 Jul;10(7):647-58. doi: 10.1111/j.1365-3156.2005.01446.x.
Rapid and accurate identification of communities at highest risk of morbidity from schistosomiasis is key for sustainable control. Although school questionnaires can effectively and inexpensively identify communities with a high prevalence of Schistosoma haematobium, parasitological screening remains the preferred option for S. mansoni. To help reduce screening costs, we investigated the validity of Lot Quality Assurance Sampling (LQAS) in classifying schools according to categories of S. mansoni prevalence in Uganda, and explored its applicability and cost-effectiveness. First, we evaluated several sampling plans using computer simulation and then field tested one sampling plan in 34 schools in Uganda. Finally, cost-effectiveness of different screening and control strategies (including mass treatment without prior screening) was determined, and sensitivity analysis undertaken to assess the effect of infection levels and treatment costs. In identifying schools with prevalences > or =50%, computer simulations showed that LQAS had high levels of sensitivity and specificity (>90%) at sample sizes <20. The method also provides an ability to classify communities into three prevalence categories. Field testing showed that LQAS where 15 children were sampled had excellent diagnostic performance (sensitivity: 100%, specificity: 96.4%, positive predictive value: 85.7% and negative predictive value: 92.3%). Screening using LQAS was more cost-effective than mass treating all schools (US$218 vs. US$482/high prevalence school treated). Threshold analysis indicated that parasitological screening and mass treatment would become equivalent for settings where prevalence > or =50% in 75% of schools and for treatment costs of US$0.19 per schoolchild. We conclude that, in Uganda, LQAS provides a rapid, valid and cost-effective method for guiding decision makers in allocating finite resources for the control of schistosomiasis.
快速准确地识别血吸虫病发病风险最高的社区是实现可持续控制的关键。虽然学校问卷调查可以有效且低成本地识别埃及血吸虫高流行社区,但寄生虫学筛查仍是曼氏血吸虫病的首选方法。为帮助降低筛查成本,我们调查了批量质量保证抽样法(LQAS)在乌干达根据曼氏血吸虫病流行类别对学校进行分类的有效性,并探讨了其适用性和成本效益。首先,我们使用计算机模拟评估了几种抽样方案,然后在乌干达的34所学校对一种抽样方案进行了实地测试。最后,确定了不同筛查和控制策略(包括未经事先筛查的群体治疗)的成本效益,并进行了敏感性分析以评估感染水平和治疗成本的影响。在识别流行率≥50%的学校时,计算机模拟显示,LQAS在样本量小于20时具有较高的敏感性和特异性(>90%)。该方法还能够将社区分为三个流行类别。实地测试表明,抽取15名儿童的LQAS具有出色的诊断性能(敏感性:100%,特异性:96.4%,阳性预测值:85.7%,阴性预测值:92.3%)。使用LQAS进行筛查比大规模治疗所有学校更具成本效益(每所高流行学校的成本为218美元,而大规模治疗为482美元)。阈值分析表明,对于75%的学校流行率≥50%且每名学童治疗成本为0.19美元的情况,寄生虫学筛查和群体治疗将具有同等效果。我们得出结论,在乌干达,LQAS为指导决策者分配有限资源以控制血吸虫病提供了一种快速、有效且具有成本效益的方法。